Marinus Pharmaceuticals Inc
NASDAQ:MRNS

Watchlist Manager
Marinus Pharmaceuticals Inc Logo
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Watchlist
Price: 0.55 USD
Market Cap: 30.4m USD

Wall Street
Price Targets

MRNS Price Targets Summary
Marinus Pharmaceuticals Inc

There are no price targets for MRNS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Marinus Pharmaceuticals Inc Competitors:
Price Targets
AHEALTH
Apex Healthcare Bhd
25% Upside
600062
China Resources Double-Crane Pharmaceutical Co Ltd
35% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
3% Downside
PFIZER
Pfizer Ltd
10% Upside
ATAI
ATAI Life Sciences NV
263% Upside
688166
BrightGene Bio-Medical Technology Co Ltd
15% Downside
TUB
Financiere de Tubize SA
43% Upside
APPH
Apontis Pharma AG
14% Upside

Revenue
Forecast

Revenue Estimate
Marinus Pharmaceuticals Inc

The compound annual growth rate of Marinus Pharmaceuticals Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Marinus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Marinus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRNS's stock price target?
Not Available

MRNS doesn't have any price targets made by Wall Street professionals.

What is Marinus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Marinus Pharmaceuticals Inc's revenue for the next 4 years is 36%.

Back to Top